跳至主要内容
临床试验/IRCT201212172017N10
IRCT201212172017N10已完成未知

The effect of Beta Glucan and both of Beta Glucan and Lactobacillus Rhamnosus GG on immune system , nutritional status and side effects of chemptherapy in breast cancer pateints

Hematology Oncology Research Center, Tabbriz University of medical Sciences0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 70 years(—)
性别
Female

入选标准

  • physician definitive diagnosis of breast cancer; receiving chemotherapy; the ability to drink at least 100 ml of water per day; life expectancy and survival at least 3 months; no allergies to molds and yeasts; adequate bone marrow function; proper function of kidney; absence of other acute medical conditions and aged 20 years and older. Exclusion criteria: patient reluctance to participate in the study; pregnant women; lactating women and existence the acute medical illness.

排除标准

  • 未提供

研究者

发起方
Hematology Oncology Research Center, Tabbriz University of medical Sciences

相似试验